Terry R Van Vleet
Company: AbbVie
Job title: Head, Investigative Toxicology & Pathology
Seminars:
Chair’s Opening Remarks 8:50 am
day: Day Two
Predicting Antibody Promiscuity Based on Physico-Chemical Bio- Properties Through Integration Of Internal Peripheral Blood Cell (PBMC) Binding Data 3:30 pm
Capturing existing peripheral blood mononuclear cell (PBMC) binding data sets to build models Applying machine learning methods to predict antibody promiscuity (PBMC binding) Identifying antibody physicochemical properties to predict and understand promiscuity for prospective antibodiesRead more
day: Day One
Chair’s Opening Remarks 8:45 am
day: Day One